U.S. federal trademark · Serial No. 77045559
products developed from in vitro tumor and nuclei culture from human cancer cells to be used for cytoreductive therapy for solid tumor cancer patients, namely, injectable pharmaceuticals
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.